| Financial Year |
March 31 2023 |
| Monetary Funds |
333,961,267.03 |
| Held-for-trading Financial Assets |
197,764,985.29 |
| Notes Receivable |
1,000,000.00 |
| Accounts Receivable |
8,363,664.33 |
| Advances to Suppliers |
6,038,625.78 |
| Other Receivables |
2,253,207.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
118,789,710.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,168,345.75 |
| Total Current Assets |
671,339,806.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,616,508.33 |
| Investment Properties |
-- |
| Fixed Assetes |
170,806,901.78 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
13,495.84 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,216,839.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
32,762,484.66 |
| Other Non-Current Assets |
303,340,012.00 |
| Sub-Total of Non-Current Assets |
565,756,242.46 |
| Total Assets |
1,237,096,048.79 |
| Short-Term Loans |
18,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
54,275,911.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,956,390.03 |
| Taxes Payable |
11,369,609.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
105,587,081.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
3,533,297.77 |
| Sub-Total of Current Liabilities |
220,192,722.57 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,753,572.35 |
| Total Liabilities |
224,946,294.92 |
| Paid-In Capital(Or Share Stock) |
185,766,000.00 |
| Capital Surplus |
192,662,417.13 |
| Surplus Reserve |
24,124,911.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
235,708,615.37 |
| Minority Stockholder's Interest |
373,887,809.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
638,261,943.90 |
| Owner's Equity（Stockholder's Equity） |
1,012,149,753.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,237,096,048.79 |
